Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx, page-99

The Independent Expert wouldn’t have been able to build in the FDA SleepCheck approval, because it was just conjecture at the time. Surely this needs to be built in before it comes out to shareholders.

But to LT holders the FDA approval builds MUCH greater confidence that they are now understanding how cough/lung/nasal sounds are indeed an accurate and a viable way to diagnose respiratory disease. Not sure the FDA timeline on Dx but there should be a spring in our step if it were to be any time soon.

And the IE will need to factor in the greater potential that Dx WILL get approval and that in turn will lift the upper price per share valuation.

Or am I just dreaming.